Late recovery of ventricular function in children with idiopathic dilated cardiomyopathy

American Heart Journal

Volumn 138, Issue 2 I, 1999, Pages 334-338

  Lewis, A B ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHILD; CHILDHOOD DISEASE; CONGESTIVE CARDIOMYOPATHY; ECHOCARDIOGRAPHY; FUNCTIONAL ASSESSMENT; HEART LEFT VENTRICLE FUNCTION; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0032777190     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(99)70121-3     Document Type: Article

References (30)

1. Lewis AB, Chabot M. Outcome of infants and children with dilated cardiomyopathy. Am J Cardiol 1991;68:365-9.
2. Lewis AB. Prognostic value of echocardiography in children with dilated cardiomyopathy. Am Heart J 1994;128:133-6.
3. Figulla HR, Rahlf G, Nieger M, et al. Spontaneous hemodynamic improvement or stabilization and associated biopsy findings in patients with congestive cardiomyopathy. Circulation 1985;71:1095-104.
4. Matitau A, Perez-Atayde A, Sanders SP, et al. Infantile dilated cardiomyopathy: relation of outcome to left ventricular mechanics, hemodynamics, and histology at the time of presentation. Circulation 1994;90:1310-8.
5. Steimle AE, Stevenson LW, Fonaroe GC, et al. Prediction of improvement in recent onset cardiomyopathy after referral for heart transplantation. J Am Coll Cardiol 1994;23:553-9.
6. Dec GW, Palacios IF, Fallon JT, et al. Active myocarditis in the spectrum of acute dilated cardiomyopathies: clinical features, histologic correlates, and clinical outcome. N Engl J Med 1985;312:885-90.
7. Griffin ML, Hernandez A, Martin TC, et al. Dilated cardiomyopathy in infants and children. J Am Coll Cardiol 1988;11:139-44.
8. Tripp ME, Katcher ML, Peters HA, et al. Systemic carnitine deficiency presenting as familial endocardial fibroelastosis: a treatable cardiomyopathy. N Engl J Med 1981;305:385-90.
9. Kelly DP, Strauss AW. Inherited cardiomyopathies. N Engl J Med 1994;330:913-9.
10. Tein I, De Vivo DC, Bierman F, et al. Impaired skin fibroblast carnitine uptake in primary systemic carnitine deficiency manifested by childhood carnitine-responsive cardiomyopathy. Pediatr Res 1990;28:247-55.
11. Rocchiccioli F, Wanders RJ, Aubourg P, et al. Deficiency of long chain 3-hydroxyacyl-CoA dehydrogenase: a cause of lethal myopathy and cardiomyopathy in early childhood. Pediatr Res 1990;28:657-62.
12. DiMauro S, Bonilla E, Zeviani M, et al. Mitochondrial myopathies. Ann Neurol 1985;17:521-38.
13. Suomalainen A, Paetau A, Leionen H, et al. Inherited idiopathic dilated cardiomyopathy with multiple deletions of mitrochondrial DNA. Lancet 1992;340:319-20.
14. Wallace DC. Diseases of the mitochondrial DNA. Annu Rev Biochem 1992;61:1175-212.
15. Schwartz ML, Cox GF, Lin AE, et al. Clinical approach to genetic cardiomyopathy in children. Circulation 1996;94:2021-38.
16. Quigley PJ, Richardson PJ, Meany BT, et al. Long-term follow-up of acute myocarditis: correlation of ventricular function and outcome. Eur Heart J 1987;8(suppl J):39-42.
17. Mason JW. Endomyocardial biopsy: the balance of success and failure. Circulation 1985;71:185-8.
18. Figulla HR, Stille-Siegener M, Mall G, et al. Myocardial enterovirus infection with left ventricular dysfunction: a benign disease compared with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1995;25:1170-5.
19. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327:685-91.
20. Sabbah HN, Shimoyama H, Kono T, et al. Effects of long-term monotherapy with enalapril, metoprolol, and digoxin on the progression of left ventricular dysfunction and dilatation in dogs with reduced ejection fraction. Circulation 1994;89:2852-9.
21. Swedberg K, Eneroth P, Kjekshus J, et al. Effects of enalapril and neuroendocrine activation on prognosis of severe congestive heart failure (follow-up of the CONSENSUS Trial). Am J Cardiol 1990;66:40-5D.
22. Davison G, Hall CS, Miller JG, et al. Cellular mechanisms of captopril-induced matrix remodeling in Syrian hamster cardiomyopathy. Circulation 1994;90:1334-42.
23. Sharpe N, Murphy J, Smith H, et al. Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction. Lancet 1988;1:255-9.
24. Packer M. Therapeutic options in the management of chronic heart failure: is there a drug of first choice? Circulation 1989;79:198-204.
25. Waagstein F, Hjalmarson Å, Varnauskas E, et al. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J 1975;37:1022-3.
26. Anderson B, Hamm C, Persson S, et al. Improved exercise hemodynamic status in dilated cardiomyopathy after beta-adrenergic blockade treatment. J Am Coll Cardiol 1994;23:1397-404.
27. Olsen SL, Gilbert E, Renlund DG, et al. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study. J Am Coll Cardiol 1995;25:1225-31.
28. Packer M, Colluci WS, Sacker-Bernstein JD, et al, for the PRECISE Study Group. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure: the PRECISE Trial. Circulation 1996;94:2793-9.
29. Heilbrunn SM, Shah P, Bristow MR, et al. Increased β-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy. Circulation 1989;79:483-90.
30. Shaddy RE, Tan LY, Gidding SS, et al. Beta blocker treatment of cardiomyopathy with congestive heart failure in children: a multi-institutional experience. J Heart Lung Transpl 1998;17:66.